Business · 20/04/2023Updated: 10/17/2026 · 1 min read
FDA Revokes Ebola EUAs for BioFire Defense and Biocartis
Summary
The FDA has revoked two Emergency Use Authorizations for Ebola diagnostic devices, issued to BioFire Defense and Biocartis, following a request from each company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →